Associated Papers
The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing data.
Zhou Y et al.
The Pharmacogenomics Journal, 2022
36068297 (PubMed )
Supplement: 41397_2022_288_MOESM4_ESM.xlsx › Sheet1
Symptom Science: Advocating for Inclusion of Functional Genetic Polymorphisms.
Knisely MR et al.
Biological Research for Nursing, 2019
31023072 (PubMed )
Supplement: supplemental_files_brn.pdf
Association of 2 neurotrophic factor polymorphisms with efficacy of paroxetine in patients with major depressive disorder in a Chinese population.
Wang XC et al.
Therapeutic Drug Monitoring, 2014
Pharmacogenetic considerations for late life depression therapy.
Pitychoutis PM et al.
Expert Opinion on Drug Metabolism & Toxicology, 2013
Select a paper to view details